RXi Names Lead Drug Candidate Selection, Corporate Partnership as Goals for 2010

RXi is "well positioned" to meet its 2010 goals of selecting a product candidate to advance into formal drug development, "refining the [company's] therapeutic focus," and consummating one or more industry partnerships, the company's new CEO said.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories